← Holders
PFM Health Sciences, LP
What PFM Health Sciences, LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1442756 · Filed Nov 16, 2026
- Positions
- 84
- Reported value
- $1B
- Opened
- 27
- Closed
- 41
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$1.3B72 positions
- Dec 31, 2025$1B78 positions
- Mar 31, 2026$1.1B83 positions
- Jun 30, 2026$1.2B98 positions
- Sep 30, 2026$1B84 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
ASNDAscendis Pharma A/S | 228.9K | −1.8% | $52.1M | 5.2% |
AXSMAxsome Therapeutics, Inc. | 222.1K | +1.1% | $41M | 4.1% |
SPDR SERIES TRUSTST STR SP BIOTPut option | 244.5K | New | $38.6M | 3.8% |
UTHRUnited Therapeutics Corp | 69.2K | +38.5% | $37.5M | 3.7% |
THCTenet Healthcare Corp | 127.3K | +0.6% | $32.5M | 3.2% |
INBXInhibrx Biosciences, Inc. | 320.3K | +3.9% | $32.1M | 3.2% |
LLYEli Lilly & Co | 25.1K | −36.1% | $29M | 2.9% |
NBIXNeurocrine Biosciences Inc | 204.3K | −4.3% | $29M | 2.9% |
INDVSupernus, Inc. | 741.9K | +84.9% | $26.6M | 2.7% |
SPYSPDR S&P 500 ETF Trust | 32.4K | New | $24.7M | 2.5% |
BBIOBridgeBio Pharma, Inc. | 365.6K | +44.3% | $24.1M | 2.4% |
TMOThermo Fisher Scientific Inc. | 32K | +12.2% | $21.6M | 2.2% |
RVMDRevolution Medicines, Inc. | 102.1K | −28.7% | $21M | 2.1% |
JAZZJazz Pharmaceuticals plc | 88.9K | −44.7% | $20.6M | 2.1% |
HUMHumana Inc | 51.1K | −45.9% | $19.5M | 1.9% |
WATWaters Corp | 43.9K | −26.6% | $19.3M | 1.9% |
UNHUnitedHealth Group Inc | 49.7K | −43.7% | $18.2M | 1.8% |
ABTAbbott Laboratories | 176.4K | +114.6% | $17.4M | 1.7% |
CYTKCytokinetics Inc | 258.8K | +35.0% | $17.1M | 1.7% |
AMRXAmneal Pharmaceuticals, Inc. | 822.9K | +71.2% | $16.6M | 1.7% |
OSCROscar Health, Inc. | 499.8K | −3.7% | $15.4M | 1.5% |
CNMDConmed Corp | 324.2K | New | $15M | 1.5% |
MDGLMadrigal Pharmaceuticals, Inc. | 28.9K | −1.5% | $14.6M | 1.5% |
TFXTeleflex Inc | 116.1K | +45.6% | $14.5M | 1.4% |
TEVATeva Pharmaceutical Industries Ltd | 355.3K | New | $14.1M | 1.4% |
ZBHZimmer Biomet Holdings, Inc. | 155.4K | New | $13.8M | 1.4% |
GKOSGlaukos Corp | 80.3K | New | $13.2M | 1.3% |
EWEdwards Lifesciences Corp | 151.8K | −39.4% | $13.1M | 1.3% |
DFTXDefinium Therapeutics, Inc. | 335.1K | +34.6% | $12.8M | 1.3% |
ISHARES TRRUSSELL 2000 ETFPut option | 45.3K | New | $12.6M | 1.3% |
VEEVVeeva Systems Inc | 39.7K | New | $11.3M | 1.1% |
GMABGenmab A/S | 313.7K | New | $11.2M | 1.1% |
EXELExelixis, Inc. | 188.8K | New | $11M | 1.1% |
IRTCiRhythm Holdings, Inc. | 96.6K | +48.2% | $11M | 1.1% |
PRAXPraxis Precision Medicines, Inc. | 36.5K | −5.4% | $10.6M | 1.1% |
CNCCentene Corp | 169.6K | −31.9% | $10.5M | 1.1% |
KODKodiak Sciences Inc. | 109.5K | −43.3% | $10.4M | 1% |
TAKTakeda Pharmaceutical Co Ltd | 567.1K | +27.7% | $10.3M | 1% |
EPRXEupraxia Pharmaceuticals Inc. | 1.1M | −6.8% | $10.3M | 1% |
DHRDanaher Corp | 45.7K | New | $10.1M | 1% |
ARWRArrowhead Pharmaceuticals, Inc. | 150K | +13.9% | $9.8M | 1% |
IARTIntegra Lifesciences Holdings Corp | 579K | +66.0% | $9.4M | 0.9% |
BLTEBelite Bio, Inc | 55.1K | +58.3% | $9.4M | 0.9% |
ICLRIcon PLC | 50.3K | −63.2% | $8.5M | 0.9% |
IONSIonis Pharmaceuticals Inc | 190.9K | New | $8.5M | 0.9% |
AMLXAmylyx Pharmaceuticals, Inc. | 282.4K | +96.5% | $8.2M | 0.8% |
ELANElanco Animal Health Inc | 344.9K | +100.0% | $7.7M | 0.8% |
BIOBio-Rad Laboratories, Inc. | 20.3K | +44.9% | $7.7M | 0.8% |
CLDXCelldex Therapeutics, Inc. | 235.8K | −31.2% | $7.6M | 0.8% |
GHGuardant Health, Inc. | 42.4K | +15.6% | $7.6M | 0.8% |
| 44.6K | New | $7.3M | 0.7% | |
BTSGBrightSpring Health Services, Inc. | 127.6K | −10.1% | $7.2M | 0.7% |
CRLCharles River Laboratories International, Inc. | 24.3K | +29.9% | $7.2M | 0.7% |
DOCSDoximity, Inc. | 226.2K | New | $6.4M | 0.6% |
VKTXViking Therapeutics, Inc. | 188.4K | −26.2% | $6.1M | 0.6% |
WSTWest Pharmaceutical Services Inc | 16.3K | −21.3% | $6M | 0.6% |
OMCLOmnicell, Inc. | 168.4K | +243.5% | $5.7M | 0.6% |
HNGEHinge Health, Inc. | 58.6K | −29.2% | $5.7M | 0.6% |
GEHCGE HealthCare Technologies Inc. | 83.6K | New | $5.5M | 0.5% |
DNTHDianthus Therapeutics, Inc. | 61.3K | −49.4% | $5.4M | 0.5% |
RYTMRhythm Pharmaceuticals, Inc. | 56K | −44.9% | $5.3M | 0.5% |
VERAVera Therapeutics, Inc. | 144K | −35.8% | $4.6M | 0.5% |
| 436.8K | New | $4.4M | 0.4% | |
OMDAOmada Health, Inc. | 210.3K | +83.8% | $4.4M | 0.4% |
HCAHCA Healthcare, Inc. | 9.7K | +16.8% | $4.1M | 0.4% |
MMEDMiniMed Group, Inc. | 204.7K | New | $4M | 0.4% |
DXCMDexCom Inc | 46.1K | New | $4M | 0.4% |
FRNMFreenome, Inc. | 231.8K | New | $3.7M | 0.4% |
CELCCelcuity Inc. | 45.4K | −13.0% | $3.6M | 0.4% |
| 20.9K | New | $3.4M | 0.3% | |
DMRADamora Therapeutics, Inc. | 144.4K | New | $3.1M | 0.3% |
OCSOculis Holding AG | 327.3K | −24.9% | $3.1M | 0.3% |
TWSTTwist Bioscience Corp | 15K | New | $2.9M | 0.3% |
IQVIQVIA Holdings Inc. | 10.7K | New | $2.9M | 0.3% |
QQQInvesco QQQ Trust, Series 1 | 3.7K | New | $2.7M | 0.3% |
ABVXAbivax S.A. | 23.9K | −44.7% | $2.4M | 0.2% |
GPCRStructure Therapeutics Inc. | 66.4K | −27.5% | $2.1M | 0.2% |
ERASErasca, Inc. | 135.1K | +0.7% | $2M | 0.2% |
TXG10x Genomics, Inc. | 20.4K | New | $1.8M | 0.2% |
SVRASavara Inc | 345.8K | New | $1.8M | 0.2% |
OMOutset Medical, Inc. | 582.1K | ±0% | $1.7M | 0.2% |
CGEMCullinan Therapeutics, Inc. | 104.7K | −45.6% | $1.6M | 0.2% |
ISHARES TRISHARES SEMICDTR | 2.5K | New | $1.4M | 0.1% |
CRBUCaribou Biosciences, Inc. | 354.7K | ±0% | $450.5K | 0.1% |